FDA-cleared K251931
BioTraceIO Vision (V1.7)
Techsomed Medical Technologies
BioTraceIO Vision V1.7 processes CT and MR images to support ablation target and needle planning and zone confirmation for the labeled liver and kidney workflows.
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Liver; kidney; and ablation target anatomy
- Decision
- 2025-09-08